MedTrace Logo

Transillumination to Reduce Post-injection Complications in Aesthetic Medicine

NCT04750421 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2021-02-15

No results posted yet for this study

Summary

Transillumination (TL) is a noninvasive technique that appears to allow preliminary detection of superficial vascular structures of the face to avoid intravascular HA injection. The purpose of our study was to test the efficacy of TL in terms of its sensitivity to locate vessels in the areas undergoing treatment and to reduce post-injection vascular complications.

Conditions

  • E05.642.500

Interventions

DEVICE

Transillumination Venolux®

Transillumination Venolux® method was used on the other half of the face before injections to visualize veins.

Sponsors & Collaborators

  • Helynck, Patrick, M.D.

    lead OTHER

Principal Investigators

  • Jean Meningaud, MD.PhD · Department of plastic and reconstructive surgery-Henri Mondor Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2018-06-01
Completion
2018-07-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04750421 on ClinicalTrials.gov